PolyPid Ownership | Who Owns PolyPid?


OverviewForecastFinancialsChartTranscripts

PolyPid Ownership Summary


PolyPid is owned by 1.97% institutional investors, and 98.03% retail investors. LUX IM Global Medtech HX is the top mutual fund, with 0.15% of its assets in PolyPid shares.

PYPD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPolyPid1.97%-98.03%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20231330.00%423,90431.97%188.32%5-4100.00%
Mar 31, 202310-28.57%321,224-15.57%139.89%5-28.57%2-33.33%
Dec 31, 202214-33.33%380,478-21.37%131.95%716.67%3-50.00%
Sep 30, 202221-30.00%483,866-54.67%28.35%6-33.33%6-33.33%
Jun 30, 202230-3.23%1,067,393-5.41%516.48%9-35.71%9125.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
LUX IM Global Medtech HX9.90K0.15%-
Yelin Lapidot Global Equity1.57K0.02%-
Yelin Lapidot Foreign Equity$Denominated851.000.01%-
Fidelity Nasdaq Composite Index418.000.01%-

PYPD Ownership FAQ


Who Owns PolyPid?

PolyPid shareholders are primarily institutional investors at 1.97%, followed by 0% insiders and 0% retail investors. The average institutional ownership in PolyPid's industry, Biotech Stocks , is 44.70%, which PolyPid falls below.

Does Blackrock own PolyPid?

BlackRock is not among the top 10 institutional shareholders of PolyPid.

Who is the top mutual fund holder of PolyPid shares?

LUX IM Global Medtech HX is the top mutual fund holder of PolyPid shares, with 0.15% of its total shares outstanding invested in 9.9K PolyPid shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools